Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent

The New England Journal of Medicine
R M ZusmanN Tolkoff-Rubin

Abstract

Anticoagulation during hemodialysis is necessary to prevent clotting of the blood on contact with the dialysis membrane. Heparin is the usual anticoagulant used, but systemic anticoagulation may persist for hours, and hemorrhage is common. We successfully used an infusion of prostacyclin, which has an in vitro half-life of three to five minutes, as the sole anticoagulant in 10 patients on long-term hemodialysis and in one patient undergoing dialysis for acute renal failure (this patient bled severely on three occasions when heparin was used). Prostacyclin was infused intravenously for 10 minutes before dialysis and into the arterial line of the dialyzer during dialysis. We adjusted the rate of infusion into the dialyzer to prevent prostacyclin-induced hypotension. Each patient completed 240 minutes of dialysis and received a total of 423 +/- 91 ng of prostacyclin per kilogram of body weight (mean +/- S.E.M.; range, 56 to 780). Prostacyclin caused no clinically important changes in the intrinsic clotting system, and there were no hemorrhages or clotting of the coil. We conclude that prostacyclin can safely replace heparin as the sole antithrombotic agent during hemodialysis and may be more advantageous if anticoagulation is cont...Continue Reading

References

Nov 18, 1978·Lancet·H F WoodsJ R Vane
Oct 1, 1979·Kidney International·R D Swartz, F K Port
Feb 1, 1977·Annals of Internal Medicine·J MilutinovichB H Scribner
Mar 1, 1975·Annals of Internal Medicine·M A GalenJ P Merrill
Jun 15, 1970·JAMA : the Journal of the American Medical Association·A TalallaT Kurze
Sep 1, 1968·The American Journal of Medicine·A C AlfreyJ H Holmes
Oct 6, 1966·The New England Journal of Medicine·C L HampersJ P Merrill
Dec 1, 1980·Kidney International

❮ Previous
Next ❯

Citations

Jan 1, 1992·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J U Leititis, M Brandis
Mar 1, 1991·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·D F GearyJ Willumsen
Jan 1, 1991·International Urology and Nephrology·M KuźniewskiJ Lisiewicz
Jan 1, 1992·International Urology and Nephrology·M Kuźniewski, W Sułowicz
Jan 1, 1982·Biomaterials·V P Addonizio, R W Colman
Jan 1, 1990·Pharmacology & Therapeutics·G J Dusting, P S MacDonald
Jan 1, 1983·General Pharmacology·E A Higgs, S Moncada
Jul 4, 1981·Lancet·S B JanvrinR M Greenhalgh
Nov 21, 1981·Lancet·S CasatiC Ponticelli
Aug 29, 1981·Lancet·G D Pearlson, A E Veroff
Jul 6, 2011·Nature Reviews. Nephrology·Andrew Davenport
Aug 27, 1981·The New England Journal of Medicine·S Casati, C Ponticelli
Feb 3, 1983·The New England Journal of Medicine·R V PinnickD A Diederich
Oct 20, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Solbjørg SagedalFrank Brosstad
Jan 12, 2000·Current Opinion in Nephrology and Hypertension·S Abramson, J L Niles
Jul 9, 2010·Nephrology·Michael Suranyi, Josephine S F Chow
May 12, 2009·Seminars in Dialysis·Kevin W Finkel, Amber S Podoll
Jul 4, 2009·Seminars in Dialysis·Miriam GalbuseraPaola Boccardo
May 1, 1983·British Heart Journal·J R Vane
Sep 1, 1985·The Journal of Clinical Investigation·T G FulghumW J Powell
Jan 1, 1983·Intensive Care Medicine·M T Weston
Jan 1, 1993·Intensive Care Medicine·R BellomoN Boyce
Feb 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M J FlaniganV S Lim
May 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·T B WiegmannD A Diederich
Feb 13, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Pieter EvenepoelYves Vanrenterghem
Sep 8, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S SchmaldienstP Knöbl
May 4, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D J KutsogiannisR T Gibney
May 1, 1990·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M B Starling, J M Neutze
Dec 1, 1993·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·M R Hagland
Dec 1, 1995·Journal of Cardiothoracic and Vascular Anesthesia·N Kieler-JensenS E Ricksten
Oct 1, 1996·Journal of Cardiothoracic and Vascular Anesthesia·N Kieler-JensenS E Ricksten
May 1, 1983·The Annals of Thoracic Surgery·G M PalatianosL W Stephenson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.